IN8bio, Inc. (INAB) Tops Q3 EPS by 2c

IN8bio, Inc. (NASDAQ: INAB) reported Q3 EPS of ($0.15), $0.02 better than the analyst estimate of ($0.17).

For earnings history and earnings-related data on IN8bio, Inc. (INAB) click here.

You May Also Be Interested In

• US government plans $4 billion loan to Vistra for nuclear upgrades - Bloomberg
• Mijem to consolidate shares 10-to-1, appoints new director
• CME Group drops plan for round-the-clock crude oil contract